Your browser doesn't support javascript.
loading
Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells.
Morales, Fátima; Ramírez, Alberto; Morata-Tarifa, Cynthia; Navarro, Saúl A; Marchal, Juan A; Campos, Joaquín M; Conejo-García, Ana.
Afiliação
  • Morales F; Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Granada 18071, Spain.
  • Ramírez A; Instituto de Biopatología y Medicina Regenerativa (IBIMER), Departamento de Anatomía y Embriología Humana, Facultad de Medicina, Granada 18071, Spain.
  • Morata-Tarifa C; Departamento de Ciencias de la Salud, Facultad de Ciencias Experimentales y de la Salud, Jaén 23071, Spain.
  • Navarro SA; Instituto de Biopatología y Medicina Regenerativa (IBIMER), Departamento de Anatomía y Embriología Humana, Facultad de Medicina, Granada 18071, Spain.
  • Marchal JA; Instituto Biosanitario de Granada (ibs.GRANADA), Hospitales Universitarios de Granada-Universidad de Granada, Granada 18071, Spain.
  • Campos JM; Instituto de Biopatología y Medicina Regenerativa (IBIMER), Departamento de Anatomía y Embriología Humana, Facultad de Medicina, Granada 18071, Spain.
  • Conejo-García A; Instituto Biosanitario de Granada (ibs.GRANADA), Hospitales Universitarios de Granada-Universidad de Granada, Granada 18071, Spain.
Future Med Chem ; 9(3): 293-302, 2017 03.
Article em En | MEDLINE | ID: mdl-28176540
ABSTRACT

AIM:

Cancer is among the leading causes of death worldwide. Medical interest has focused on macrocyclic polyamines because of their properties as antitumor agents. Results/

Methodology:

We have designed and synthesized a series of 1,2-diaminocyclohexane derivatives with notable in vitro antiproliferative activities against the MCF-7, HCT-116 and A375 cancer cell lines. Cell cycle and apoptosis analyses were also carried out. Our results show that all the compounds are potent cytotoxic agents, especially against the A375 cell line.

CONCLUSION:

The selective activity of the macrocyclic derivative against A375, via apoptosis, supposes a great advantage for future therapeutic use. This exemplifies the potential of 1,2-diaminocyclohexane derivatives to qualify as lead structures for future anticancer drug development due to their easy syntheses and noteworthy bioactivity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cicloexilaminas / Proliferação de Células / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cicloexilaminas / Proliferação de Células / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article